港股创新药概念股持续拉升，和铂医药-B涨近10%
HBM HOLDINGSHBM HOLDINGS(HK:02142) Xin Lang Cai Jing·2025-09-03 02:53

Core Viewpoint - The Hong Kong stock market's innovative drug concept stocks are experiencing significant gains, with notable increases in share prices for several companies [1] Company Summaries - Heptagon Pharmaceuticals-B has surged nearly 10% [1] - CSPC Pharmaceutical Group and Innovent Biologics have both risen over 5% [1] - Zai Lab, Sinopharm Group, and China National Pharmaceutical Group are among the top gainers in this sector [1]